PRESS RELEASE published on 06/20/2023 at 14:00, 1 year 5 months ago CO2 GRO Signs ~CAD $1 million Sales Contract with El Salvador-based Hidroexpo
PRESS RELEASE published on 05/24/2023 at 15:55, 1 year 5 months ago CO2 GRO Receives ~$500,000 CAD Sales Order from a Major Canadian Vegetable Greenhouse Grower
PRESS RELEASE published on 04/26/2023 at 14:00, 1 year 6 months ago CO2 GRO Inc. Proudly Releases its 2023 ESG Report Highlighting Significant Environmental, Social, and Governance Opportunity Updates
PRESS RELEASE published on 01/27/2023 at 22:30, 1 year 9 months ago CO2 GRO Inc. Grants Restricted Share Units
Published on 11/21/2024 at 14:00, 14 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 14 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 14 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 44 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 38 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 59 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 16 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 54 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
